[
  {
    "ts": null,
    "headline": "Rosen Law Firm Urges Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Stockholders to Contact the Firm for Information About Their Rights",
    "summary": "Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023...",
    "url": "https://finnhub.io/api/news?id=e084b4a91a1808e80d9de5ced0184bd61eb57afc37f344025e6b362040d2b2a7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736882223,
      "headline": "Rosen Law Firm Urges Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Stockholders to Contact the Firm for Information About Their Rights",
      "id": 132396389,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023...",
      "url": "https://finnhub.io/api/news?id=e084b4a91a1808e80d9de5ced0184bd61eb57afc37f344025e6b362040d2b2a7"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Reports Eylea Sales, Provides Other Pipeline Updates",
    "summary": "REGN announces business updates at the J.P. Morgan Healthcare Conference. The company also reports sales for Eylea and Eylea HD (on a preliminary basis).",
    "url": "https://finnhub.io/api/news?id=62123ae2fc69dc12decf2c3c12760456f28ad92c5df6d03284a383125219cbbc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736880600,
      "headline": "Regeneron Reports Eylea Sales, Provides Other Pipeline Updates",
      "id": 132439113,
      "image": "https://media.zenfs.com/en/zacks.com/134262e7450b675c3e292544e53a733c",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "REGN announces business updates at the J.P. Morgan Healthcare Conference. The company also reports sales for Eylea and Eylea HD (on a preliminary basis).",
      "url": "https://finnhub.io/api/news?id=62123ae2fc69dc12decf2c3c12760456f28ad92c5df6d03284a383125219cbbc"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron CSO Yancopoulos on Weight-Loss Drugs, Pipeline",
    "summary": "-- Regeneron Co-Chair, President and CSO George Yancopoulos discusses the company's planned weight-loss drugs with Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco....",
    "url": "https://finnhub.io/api/news?id=ac489de90002b7a3c1396874bc6bd9f13fd51b6c0a8e458d66f95ea67e70569a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736857464,
      "headline": "Regeneron CSO Yancopoulos on Weight-Loss Drugs, Pipeline",
      "id": 132394776,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "-- Regeneron Co-Chair, President and CSO George Yancopoulos discusses the company's planned weight-loss drugs with Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco....",
      "url": "https://finnhub.io/api/news?id=ac489de90002b7a3c1396874bc6bd9f13fd51b6c0a8e458d66f95ea67e70569a"
    }
  },
  {
    "ts": null,
    "headline": "Deadline Approaching: Regeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith",
    "summary": "Law Offices of Howard G. Smith reminds investors of the upcoming March 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Regeneron...",
    "url": "https://finnhub.io/api/news?id=cceb341f7c2e6de4dd3c8f92b9521fb2a3081629a44f30a93dd115f286800cda",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736856124,
      "headline": "Deadline Approaching: Regeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith",
      "id": 132394658,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Law Offices of Howard G. Smith reminds investors of the upcoming March 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Regeneron...",
      "url": "https://finnhub.io/api/news?id=cceb341f7c2e6de4dd3c8f92b9521fb2a3081629a44f30a93dd115f286800cda"
    }
  },
  {
    "ts": null,
    "headline": "Shareholders that lost money on Regeneron Pharmaceuticals, Inc.(REGN) should contact Levi & Korsinsky about pending Class Action - REGN",
    "summary": "NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. of a class action securities lawsuit. ...",
    "url": "https://finnhub.io/api/news?id=d4dea5476f95b6aa6d6d37bd284b349e0d19c30294f7525307acb8b4d4886d71",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736833585,
      "headline": "Shareholders that lost money on Regeneron Pharmaceuticals, Inc.(REGN) should contact Levi & Korsinsky about pending Class Action - REGN",
      "id": 132392690,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. of a class action securities lawsuit. ...",
      "url": "https://finnhub.io/api/news?id=d4dea5476f95b6aa6d6d37bd284b349e0d19c30294f7525307acb8b4d4886d71"
    }
  }
]